Reduced prevalence of cognitive impairment in families with exceptional longevity
- PMID: 23649824
- PMCID: PMC4151346
- DOI: 10.1001/jamaneurol.2013.1959
Reduced prevalence of cognitive impairment in families with exceptional longevity
Abstract
Importance: Family studies of centenarians and long-lived persons have found substantial familial aggregation of survival to extreme ages; however, the extent to which such familial longevity is characterized by cognitively intact survival is not established.
Objective: To determine whether families with exceptional longevity are protected against cognitive impairment consistent with Alzheimer disease.
Design: Cross-sectional analysis.
Setting: Multisite study in New York, Massachusetts, Pennsylvania, and Denmark.
Participants: A total of 1870 individuals (1510 family members and 360 spouse controls) recruited through the Long Life Family Study.
Main outcome and measure: Prevalence of cognitive impairment based on a diagnostic algorithm validated using the National Alzheimer's Coordinating Center data set.
Results: The cognitive algorithm classified 546 individuals (38.5%) as having cognitive impairment consistent with Alzheimer disease. Long Life Family Study probands had a slightly but not statistically significant reduced risk of cognitive impairment compared with spouse controls (121 of 232 for probands vs 45 of 103 for spouse controls; odds ratio = 0.7; 95% CI, 0.4-1.4), whereas Long Life Family Study sons and daughters had a clearly reduced risk of cognitive impairment (11 of 213 for sons and daughters vs 28 of 216 for spouse controls; odds ratio = 0.4; 95% CI, 0.2-0.9). Restriction to nieces and nephews in the offspring generation attenuated this effect (37 of 328 for nieces and nephews vs 28 of 216 for spouse controls; odds ratio = 0.8; 95% CI, 0.4-1.4).
Conclusions and relevance: Rates of cognitive impairment characteristic of Alzheimer disease were relatively high. In the proband generation, rates were comparable across family members and spouse controls, whereas sons and daughters of probands had significantly lower rates than spouse controls. Results suggest a delayed onset of cognitive impairment in families with exceptional longevity, but assessment of age-specific incidence rates is required to confirm this hypothesis.
Figures
Similar articles
-
Slower Decline in Processing Speed Is Associated with Familial Longevity.Gerontology. 2022;68(1):17-29. doi: 10.1159/000514950. Epub 2021 May 4. Gerontology. 2022. PMID: 33946077 Free PMC article.
-
Age-specific incidence rates for dementia and Alzheimer disease in NIA-LOAD/NCRAD and EFIGA families: National Institute on Aging Genetics Initiative for Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease (NIA-LOAD/NCRAD) and Estudio Familiar de Influencia Genetica en Alzheimer (EFIGA).JAMA Neurol. 2014 Mar;71(3):315-23. doi: 10.1001/jamaneurol.2013.5570. JAMA Neurol. 2014. PMID: 24425039 Free PMC article.
-
Age-Related Biomarkers in LLFS Families With Exceptional Cognitive Abilities.J Gerontol A Biol Sci Med Sci. 2017 Nov 9;72(12):1683-1688. doi: 10.1093/gerona/glx034. J Gerontol A Biol Sci Med Sci. 2017. PMID: 28329324 Free PMC article.
-
Alzheimer's disease in humans and other animals: A consequence of postreproductive life span and longevity rather than aging.Alzheimers Dement. 2018 Feb;14(2):195-204. doi: 10.1016/j.jalz.2017.08.014. Epub 2017 Sep 30. Alzheimers Dement. 2018. PMID: 28972881 Review.
-
Finances in the older patient with cognitive impairment: "He didn't want me to take over".JAMA. 2011 Feb 16;305(7):698-706. doi: 10.1001/jama.2011.164. JAMA. 2011. PMID: 21325186 Free PMC article. Review.
Cited by
-
Genetics of Human Longevity From Incomplete Data: New Findings From the Long Life Family Study.J Gerontol A Biol Sci Med Sci. 2018 Oct 8;73(11):1472-1481. doi: 10.1093/gerona/gly057. J Gerontol A Biol Sci Med Sci. 2018. PMID: 30299504 Free PMC article.
-
Patterns of multi-domain cognitive aging in participants of the Long Life Family Study.Geroscience. 2020 Oct;42(5):1335-1350. doi: 10.1007/s11357-020-00202-3. Epub 2020 Jun 8. Geroscience. 2020. PMID: 32514870 Free PMC article.
-
Age and Sex Distributions of Age-Related Biomarker Values in Healthy Older Adults from the Long Life Family Study.J Am Geriatr Soc. 2016 Nov;64(11):e189-e194. doi: 10.1111/jgs.14522. Epub 2016 Oct 26. J Am Geriatr Soc. 2016. PMID: 27783390 Free PMC article.
-
Slower Decline in Processing Speed Is Associated with Familial Longevity.Gerontology. 2022;68(1):17-29. doi: 10.1159/000514950. Epub 2021 May 4. Gerontology. 2022. PMID: 33946077 Free PMC article.
-
Low untreated systolic blood pressure over 18 years is associated with survival free of dementia age 90.Alzheimers Dement. 2022 Nov;18(11):2176-2187. doi: 10.1002/alz.12493. Epub 2022 Jan 28. Alzheimers Dement. 2022. PMID: 35089640 Free PMC article.
References
-
- NIA Aging and Genetic Epidemiology Working Group. Genetic epidemiologic studies on age-specific traits. American Journal of Epidemiology. 2000;152:1003–1008. - PubMed
-
- Ebly EM, Parhad IM, Hogan DB, Fung TS. Prevalence and types of dementia in the very old: results from the Canadian Study of Health and Aging. Neurology. 1994;44:1593–1600. - PubMed
-
- Graves AB, Larson EB, Edland SD, et al. Prevalence of dementia and its subtypes in the Japanese American population of King County, Washington state. The Kame Project. Am J Epidemiol. 1996;144:760–771. - PubMed
-
- Ritchie K, Kildea D. Is senile dementia age-related or ageing-related: evidence from meta-analysis of dementia prevalence in the oldest old. Lancet. 1997;346 - PubMed
-
- von Strauss E, Viitanen M, De Ronchi D, Winblad B, Fratiglioni L. Aging and the occurrence of dementia: findings from a population-based cohort with a large sample of nonagenarians. Arch Neurol. 1999;56:587–592. - PubMed
Publication types
MeSH terms
Grants and funding
- U01 AG023712/AG/NIA NIH HHS/United States
- U01 AG023744/AG/NIA NIH HHS/United States
- K23AG032899/AG/NIA NIH HHS/United States
- U01 AG016976/AG/NIA NIH HHS/United States
- K23 AG032899/AG/NIA NIH HHS/United States
- P30 AG034424/AG/NIA NIH HHS/United States
- P01 AG08761/AG/NIA NIH HHS/United States
- U01 AG023749/AG/NIA NIH HHS/United States
- U01-AG023712/AG/NIA NIH HHS/United States
- U01 AG023755/AG/NIA NIH HHS/United States
- P01 AG008761/AG/NIA NIH HHS/United States
- U01 AG023746/AG/NIA NIH HHS/United States
- U01-AG23744/AG/NIA NIH HHS/United States
- U01-AG023749/AG/NIA NIH HHS/United States
- U01-AG023755/AG/NIA NIH HHS/United States
- U01-AG023746/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical